Simplex Trading’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Simplex Trading’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-74,764	Closed	-$17K	–	10470
2023 Q1	$17K	Buy	74,764 +73,665	+6,703%	+$26.2K	﹤0.01%	7102
2022 Q4	$0	Sell	1,099 -18,558	-94%	-$11.8K	﹤0.01%	10945
2022 Q3	$20K	Sell	19,657 -19,875	-50%	-$45.3K	﹤0.01%	7555
2022 Q2	$73K	Sell	39,532 -7,204	-15%	-$17.5K	﹤0.01%	5991
2022 Q1	$166K	Sell	46,736 -14,196	-23%	-$69.7K	﹤0.01%	5426
2021 Q4	$524K	Buy	60,932 +60,889	+141,602%	+$387K	﹤0.01%	3718
2021 Q3	$0	Hold	43	–	–	﹤0.01%	9955
2021 Q2	$0	Buy	+43	New	+$271	﹤0.01%	10939

Other funds holding LHDX

Resolute Advisors San Francisco, California $417M AUM 60.99% 1-Year Est. Return

Simplex Trading's LHDX Position: Q2 2023 in Review

Simplex Trading sold out of Lucira Health, Inc. Common Stock (LHDX) in Q2 2023, closing a stake of 74,764 shares — an estimated $17K sold.

Simplex Trading first reported a position in LHDX in Q2 2021 and held it in 8 quarters. The position peaked at $524K in Q4 2021. 1 fund tracked by Wall St. Rank holds LHDX as of Q2 2023.

Simplex Trading reported no remaining Lucira Health, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Simplex Trading sold 74,764 Lucira Health, Inc. Common Stock shares in Q2 2023, an estimated $17K.
Simplex Trading first reported a position in Lucira Health, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
Simplex Trading's Lucira Health, Inc. Common Stock position peaked at $524K in Q4 2021.
1 fund tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.